137 related articles for article (PubMed ID: 22265734)
1. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
Nuyttens JJ; van der Voort van Zyp NC; Praag J; Aluwini S; van Klaveren RJ; Verhoef C; Pattynama PM; Hoogeman MS
Radiother Oncol; 2012 Mar; 102(3):383-7. PubMed ID: 22265734
[TBL] [Abstract][Full Text] [Related]
2. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
4. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer.
Olsen JR; Robinson CG; El Naqa I; Creach KM; Drzymala RE; Bloch C; Parikh PJ; Bradley JD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e299-303. PubMed ID: 21477948
[TBL] [Abstract][Full Text] [Related]
5. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
[TBL] [Abstract][Full Text] [Related]
6. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.
Hamamoto Y; Kataoka M; Yamashita M; Shinkai T; Kubo Y; Sugawara Y; Inoue T; Sakai S; Aono S; Takahashi T; Semba T; Uwatsu K
Jpn J Clin Oncol; 2010 Feb; 40(2):125-9. PubMed ID: 19825814
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
Videtic GM; Stephans K; Reddy C; Gajdos S; Kolar M; Clouser E; Djemil T
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):344-9. PubMed ID: 19765913
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
9. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
[TBL] [Abstract][Full Text] [Related]
11. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
[TBL] [Abstract][Full Text] [Related]
17. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
[TBL] [Abstract][Full Text] [Related]
19. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
McCammon R; Schefter TE; Gaspar LE; Zaemisch R; Gravdahl D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):112-8. PubMed ID: 18786780
[TBL] [Abstract][Full Text] [Related]
20. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
